Effect of Perioperative Dexmedetomidine Administration on Outcome in Cardiac Surgery Patients
- Registration Number
- NCT03091166
- Lead Sponsor
- Moscow Regional Research and Clinical Institute (MONIKI)
- Brief Summary
Investigation of effect of perioperative Dexmedetomedine administration on mortality, length of ICU and hospital stay, delirium onset, major adverse cardiac and cerebrovascular events, acute kidney injury in cardiac surgery patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 169
Inclusion Criteria
- Written informed agreement
- Elective surgery
- Use of CPB
Read More
Exclusion Criteria
- Previous prolonged immobilization
- Reoperation
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Dexmedetomidine Dexmedetomidine -
- Primary Outcome Measures
Name Time Method 30DM 30 days after surgery 30-day mortality
Delirium 30 days after surgery Postoperative delirium
- Secondary Outcome Measures
Name Time Method VIS 5 days after surgery Vasoactive- Inotropic Score
AKI 7 days after surgery Acute kidney injury
Subsyndromal delirium 30 days after surgery Subsyndromal postoperative delirium
ICU-LOS 7 days after surgery Length of ICU stay
H-LOS 30 days after surgery Hospital length of stay
MACCE 30 days after surgery Major adverse cardiac and cerebrovascular events
Trial Locations
- Locations (1)
Moscow Regional Research and Clinical Institute Moniki n.a. M.F. Vladimirskiy
🇷🇺Moscow, Russian Federation